Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Flexner

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Current Opinion in HIV and AIDS|October 9, 2013
Optimization and simplification of antiretroviral therapy for adults and childrenNathan Ford, Charles Flexner, Stefano Vella, et al.
Annals of Internal Medicine|September 30, 2014
Forecast for the Physician Payment Sunshine Act: partly to mostly cloudy?Stephanie R Morain, Charles Flexner, Nancy E Kass, et al.
Trends in Pharmacological Sciences|April 23, 2022
Supramolecular nanomedicines through rational design of self-assembling prodrugsHan Wang, Maya Monroe, Faith Leslie, et al.
The Journal of Infectious Diseases|July 27, 2011
The critical need for alternative antiretroviral formulations, and obstacles to their developmentSusan Swindells, Charles Flexner, Courtney V Fletcher, et al.
The AIDS Reader|July 31, 2004
Simplifying antiretroviral therapyMichael L Tapper, Charles Flexner, Joseph J Eron, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2020
Predicting Pharmacokinetics of a Tenofovir Alafenamide Subcutaneous Implant Using Physiologically Based Pharmacokinetic ModellingRajith K R Rajoli, Zach R Demkovich, Charles Flexner, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|June 18, 2011
When a serious adverse event in research occurs, how do other volunteers react?Caitlin E Kennedy, Nancy Kass, Rachel K Myers, et al.
Journal of the American Chemical Society|September 25, 2023
Constructing Antiretroviral Supramolecular Polymers as Long-Acting Injectables through Rational Design of Drug Amphiphiles with Alternating Antiretroviral-Based and Hydrophobic ResiduesHan Wang, Maya K Monroe, Feihu Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2022
Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infectionsMaya K Monroe, Han Wang, Caleb F Anderson, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
Pharmacokinetics of darunavir at 900 milligrams and ritonavir at 100 milligrams once daily when coadministered with efavirenz at 600 milligrams once daily in healthy volunteersGaik H Soon, Ping Shen, Eu-Leong Yong, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Current Opinion in HIV and AIDS|October 9, 2013
Optimization and simplification of antiretroviral therapy for adults and childrenNathan Ford, Charles Flexner, Stefano Vella, et al.
Annals of Internal Medicine|September 30, 2014
Forecast for the Physician Payment Sunshine Act: partly to mostly cloudy?Stephanie R Morain, Charles Flexner, Nancy E Kass, et al.
Trends in Pharmacological Sciences|April 23, 2022
Supramolecular nanomedicines through rational design of self-assembling prodrugsHan Wang, Maya Monroe, Faith Leslie, et al.
The Journal of Infectious Diseases|July 27, 2011
The critical need for alternative antiretroviral formulations, and obstacles to their developmentSusan Swindells, Charles Flexner, Courtney V Fletcher, et al.
The AIDS Reader|July 31, 2004
Simplifying antiretroviral therapyMichael L Tapper, Charles Flexner, Joseph J Eron, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2020
Predicting Pharmacokinetics of a Tenofovir Alafenamide Subcutaneous Implant Using Physiologically Based Pharmacokinetic ModellingRajith K R Rajoli, Zach R Demkovich, Charles Flexner, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|June 18, 2011
When a serious adverse event in research occurs, how do other volunteers react?Caitlin E Kennedy, Nancy Kass, Rachel K Myers, et al.
Journal of the American Chemical Society|September 25, 2023
Constructing Antiretroviral Supramolecular Polymers as Long-Acting Injectables through Rational Design of Drug Amphiphiles with Alternating Antiretroviral-Based and Hydrophobic ResiduesHan Wang, Maya K Monroe, Feihu Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2022
Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infectionsMaya K Monroe, Han Wang, Caleb F Anderson, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
Pharmacokinetics of darunavir at 900 milligrams and ritonavir at 100 milligrams once daily when coadministered with efavirenz at 600 milligrams once daily in healthy volunteersGaik H Soon, Ping Shen, Eu-Leong Yong, et al.
Pageof 14